Most Read Articles
24 Dec 2017
Losartan at 50 mg is effective in reducing blood pressure in patients with postdialysis euvolemic hypertension, a recent study has shown.
29 Dec 2017
Preoperative hyponatraemia and higher body mass index (BMI) before surgery increase the risk of postoperative stress-related cardiomyopathy (SRC), according to a recent study.
24 Dec 2017
Cardiovascular (CV) diseases or CV risk factors account for the reduced quality of life (QOL) in diabetics compared with nondiabetics, a recent study has found.
24 Dec 2017
The CENTERA transcatheter heart valve (THV) has been proven safe and effective in high-surgical-risk patients with severe symptomatic aortic stenosis at 30 days, resulting in low mortality, significant improvements in haemodynamic outcomes, and low incidence of adverse events, according to a study.

Sex steroids affect cardiovascular outcomes in transgender individuals

13 Nov 2017

Sex steroid therapy appears to elevate low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) levels and reduce high-density lipoprotein cholesterol (HDL-C) levels in female-to-male (FTM) individuals, while oral oestrogens appear to increase TG levels in male-to-female (MTF) individuals, suggests a study with low-quality evidence. Moreover, data on significant patient outcomes are still lacking.

Researchers conducted a comprehensive search of several databases up to 7 April 2015 for studies evaluating the effect of sex steroid use on lipids, myocardial infarction, stroke, venous thromboembolism (VTE) and mortality in transgender individuals. A random-effects model was used to pool weighted mean differences and 95 percent confidence intervals (CIs).

A total of 29 studies with moderate risk of bias met the inclusion criteria. Sex steroid in FTM individuals correlated with statistically significant increases in serum TG levels at 3 to 6 months and at ≥24 months (21.4 mg/dL; 95 percent CI, 0.14 to 42.6) and in LDL-C levels at 12 and ≥24 months (17.8 mg/dL; 3.5 to 32.1). There was a significant reduction in HDL-C levels across all follow-up periods (highest at ≥24 months, −8.5 mg/dL; −13.0 to −3.9).

Serum TG levels were significantly greater in MTF individuals at ≥24 months (31.9 mg/dL; 3.9 to 59.9) without any changes in other parameters. There were few reports of myocardial infarction, stroke, VTE and death events, and these more frequently occurred among MTF individuals.

“Transgender individuals receive cross-sex hormonal therapy to induce desired secondary sexual characteristics despite limited data regarding its effects on cardiovascular health,” according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
24 Dec 2017
Losartan at 50 mg is effective in reducing blood pressure in patients with postdialysis euvolemic hypertension, a recent study has shown.
29 Dec 2017
Preoperative hyponatraemia and higher body mass index (BMI) before surgery increase the risk of postoperative stress-related cardiomyopathy (SRC), according to a recent study.
24 Dec 2017
Cardiovascular (CV) diseases or CV risk factors account for the reduced quality of life (QOL) in diabetics compared with nondiabetics, a recent study has found.
24 Dec 2017
The CENTERA transcatheter heart valve (THV) has been proven safe and effective in high-surgical-risk patients with severe symptomatic aortic stenosis at 30 days, resulting in low mortality, significant improvements in haemodynamic outcomes, and low incidence of adverse events, according to a study.